Bio: Girish Putcha is currently Director of Laboratory Science for Palmetto GBA’s MolDX program, which oversees coverage and reimbursement for molecular testing for over half of the Medicare population. He also serves as Chief Medical Officer and Laboratory Director at Freenome, a health technology company developing tools for the prevention, detection and treatment of diseases, such as cancer.
Previously, Girish was the founding Laboratory Director and/or Chief Medical Officer at Ariosa Diagnostics, Crescendo Bioscience, Life Technologies, and VitaPath Genetics. Prior to this, he focused on investments across healthcare, from biopharmaceuticals and medical devices to diagnostics and services, at Panorama Capital and RiverVest Venture Partners, where he also served on the boards of several portfolio companies, including Presidio Pharmaceuticals, PowerVision, and Phenomix. He was also a founding team member at VeraCyte and a clinical development fellow at CardioDx, both venture-funded personalized medicine companies.
Girish received a bachelor’s degree from Rice University and master’s degrees from the University of London and the Welcome Institute as a Marshall Scholar. He holds medical and doctoral degrees from Washington University School of Medicine, where he also did a postdoctoral fellowship in molecular neuroscience. Girish completed his postgraduate medical training at the Stanford University School of Medicine, where he also served as adjunct clinical faculty, specializing in molecular genetic pathology.